4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Faeth Therapeutics, Inc. (FTH) operates in the Biotechnology industry and is headquartered in Rockville, United States with about 29 employees. Its market capitalization is roughly $820 million. In the fiscal year ended 2025-12-31, FTH reported $0M in revenue and ($21M) in net income.
Faeth Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company offers PIKTOR, an investigational multi-node inhibitor of the PI3K/AKT/mTOR pathway in development for endometrial and breast cancer.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($22M) | ($32M) | ($37M) | ($50M) | — |
| Net Income | ($21M) | ($30M) | ($34M) | ($49M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($171M) | ($5M) | ($5M) | ($5M) | ($7M) | — |
| Net Income | ($170M) | ($5M) | ($5M) | ($5M) | ($7M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $23M | $45M | $74M | $118M | — |
| Total Liabilities | $4M | $7M | $10M | $15M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive FTH viewer.
About TickerBase · Data methodology & sources